{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:20:12Z","timestamp":1787876412392,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-026-00904-2","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:19:48Z","timestamp":1781777988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of virologic failure among adult HIV patients on first-line antiretroviral therapy in health facilities of Awi Zone, northwest Ethiopia: a case-control study"],"prefix":"10.1186","volume":"23","author":[{"given":"Daniel Mulat","family":"Eshetu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikias Getahun","family":"Molla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abebe","family":"Yeshambel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habtamu Getahun","family":"Molla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulatu","family":"Kassahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"Suppl 1","key":"904_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4314\/ejhs.v27i1.1S","volume":"27","author":"G Barnabas","year":"2017","unstructured":"Barnabas G, Sibhatu MK, Berhane Y. Antiretroviral therapy program in Ethiopia benefits from virology treatment monitoring. Ethiop J health Sci. 2017;27(Suppl 1):1.","journal-title":"Ethiop J health Sci"},{"issue":"1","key":"904_CR2","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1186\/s12879-022-07797-2","volume":"22","author":"ST Mengistu","year":"2022","unstructured":"Mengistu ST, Ghebremeskel GG, Ghebrat HB, Achila OO, Yohannes NA, Ghebrenegus AS, et al. Determinants of therapy failure among adults on first-line antiretroviral therapy in Asmara, Eritrea: a multicenter retrospective matched case\u2013control study. BMC Infect Dis. 2022;22(1):834.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"904_CR3","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1111\/j.1365-3156.2011.02874.x","volume":"16","author":"R Kanapathipillai","year":"2011","unstructured":"Kanapathipillai R, McGuire M, Mogha R, Szumilin E, Heinzelmann A, Pujades-Rodr\u00edguez M. Benefit of viral load testing for confirmation of immunological failure in HIV patients treated in rural Malawi. Tropical Med Int Health. 2011;16(12):1495\u2013500.","journal-title":"Tropical Med Int Health"},{"key":"904_CR4","volume-title":"Ethiopia Population based HIV Impact Assessment (EPHIA) 2017\u20132018: Final Report","author":"Ethiopia Public Health Institute","year":"2020","unstructured":"Ethiopia Public Health Institute. Ethiopia Population based HIV Impact Assessment (EPHIA) 2017\u20132018: Final Report. Addis Ababa, Ethiopia: EPHI; 2020."},{"key":"904_CR5","doi-asserted-by":"crossref","unstructured":"Worku ED, Asemahagn MA, Endalifer ML. Epidemiology of HIV infection in the Amhara region of Ethiopia, 2015 to 2018 surveillance data analysis. HIV\/AIDS-Research and Palliative Care. 2020:307\u201314.","DOI":"10.2147\/HIV.S253194"},{"issue":"1","key":"904_CR6","first-page":"8909232","volume":"2020","author":"G Diress","year":"2020","unstructured":"Diress G, Dagne S, Alemnew B, Adane S, Addisu A. Viral load suppression after enhanced adherence counseling and its predictors among high viral load HIV seropositive people in north wollo zone public hospitals, northeast Ethiopia, 2019: retrospective cohort study. AIDS Res Treat. 2020;2020(1):8909232.","journal-title":"AIDS Res Treat"},{"issue":"8","key":"904_CR7","doi-asserted-by":"publisher","first-page":"e0272405","DOI":"10.1371\/journal.pone.0272405","volume":"17","author":"L Frescura","year":"2022","unstructured":"Frescura L, Godfrey-Faussett P, Feizzadeh A, El-Sadr W, Syarif O, Ghys PD, et al. Achieving the 95 95 95 targets for all: A pathway to ending AIDS. PLoS ONE. 2022;17(8):e0272405.","journal-title":"PLoS ONE"},{"key":"904_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/hiv.12716","volume":"20","author":"S Moreno","year":"2019","unstructured":"Moreno S, Perno C, Mallon P, Behrens G, Corbeau P, Routy JP, et al. Two-drug vs. three\u2010drug combinations for HIV\u20101: do we have enough data to make the switch? HIV Med. 2019;20:2\u201312.","journal-title":"HIV Med"},{"key":"904_CR9","doi-asserted-by":"crossref","unstructured":"Desta AA, Kidane KM, Woldegebriel AG, Ajemu KF, Berhe AA, Zgita DN et al. Level of adherence and associated factors among HIV-infected patients on antiretroviral therapy in Northern Ethiopia: retrospective analysis. Patient Prefer Adherence. 2020:1585\u201394.","DOI":"10.2147\/PPA.S268395"},{"key":"904_CR10","unstructured":"World Health Organization. What\u2019s new in treatment monitoring: viral load and CD4 testing. Geneva: WHO. 2017 [Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2017.22"},{"key":"904_CR11","doi-asserted-by":"publisher","first-page":"916454","DOI":"10.3389\/fpubh.2022.916454","volume":"10","author":"B Bogale","year":"2022","unstructured":"Bogale B, Asefa A, Destaw A, Midaksa G, Asaye Z, Alemu Gebremichael M, et al. Determinants of virological failure among patients on first line highly active antiretroviral therapy (HAART) in Southwest Ethiopia: a case-control study. Front Public Health. 2022;10:916454.","journal-title":"Front Public Health"},{"issue":"51","key":"904_CR12","doi-asserted-by":"publisher","first-page":"e28357","DOI":"10.1097\/MD.0000000000028357","volume":"100","author":"J Siraj","year":"2021","unstructured":"Siraj J, Feyissa D, Mamo Y, Zewudie A, Regesa T, Ejeta F, et al. Antiretroviral treatment failure and associated factors among HIV patients on the first-line antiretroviral therapy at Mizan-Tepi University teaching hospital, Southwest Ethiopia: a cross-sectional study. Medicine. 2021;100(51):e28357.","journal-title":"Medicine"},{"issue":"7","key":"904_CR13","doi-asserted-by":"publisher","first-page":"e036223","DOI":"10.1136\/bmjopen-2019-036223","volume":"10","author":"HM Meshesha","year":"2020","unstructured":"Meshesha HM, Nigussie ZM, Asrat A, Mulatu K. Determinants of virological failure among adults on first-line highly active antiretroviral therapy at public health facilities in Kombolcha town, Northeast, Ethiopia: a case\u2013control study. BMJ open. 2020;10(7):e036223.","journal-title":"BMJ open"},{"key":"904_CR14","volume-title":"Multilevel analysis: an introduction to basic and advanced multilevel modeling","author":"TABBR Snijders","year":"2011","unstructured":"Snijders TABBR. Multilevel analysis: an introduction to basic and advanced multilevel modeling. 2nd ed. London: Sage Publications Ltd; 2011.","edition":"2"},{"key":"904_CR15","doi-asserted-by":"publisher","DOI":"10.4324\/9781315650982","volume-title":"Multilevel analysis: techniques and applications","author":"J Hox","year":"2017","unstructured":"Hox J, Moerbeek M, Van de Schoot R. Multilevel analysis: techniques and applications. 3rd ed. London: Routledge; 2017.","edition":"3"},{"key":"904_CR16","first-page":"69","volume":"8","author":"HA Mekonnen","year":"2023","unstructured":"Mekonnen HA, Aregaw FM, Yesuf T, Derseh NM. Prevalence of virologic failure and determinants among adults on first-line antiretroviral therapy at debre tabor comprehensive specialized hospital in Northwest Ethiopia. Int J Infect Dis Ther. 2023;8:69\u201379.","journal-title":"Int J Infect Dis Ther"},{"key":"904_CR17","doi-asserted-by":"publisher","first-page":"1440504","DOI":"10.3389\/fpubh.2025.1440504","volume":"13","author":"E Zerihun","year":"2025","unstructured":"Zerihun E, Tesema K, Abera F. Virological treatment failure and associated factors among adults on first-line antiretroviral therapy in West Hararghe, Ethiopia. Front Public Health. 2025;13:1440504.","journal-title":"Front Public Health"},{"issue":"1","key":"904_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2458-8-81","volume":"8","author":"K Deribe","year":"2008","unstructured":"Deribe K, Woldemichael K, Wondafrash M, Haile A, Amberbir A. Disclosure experience and associated factors among HIV positive men and women clinical service users in southwest Ethiopia. BMC Public Health. 2008;8(1):81.","journal-title":"BMC Public Health"},{"issue":"5","key":"904_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/apc.2006.20.359","volume":"20","author":"LS Rintamaki","year":"2006","unstructured":"Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDs. 2006;20(5):359\u201368.","journal-title":"AIDS Patient Care STDs"},{"issue":"6","key":"904_CR20","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1007\/s10461-009-9593-3","volume":"13","author":"VA Earnshaw","year":"2009","unstructured":"Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160\u201377.","journal-title":"AIDS Behav"},{"issue":"1","key":"904_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s42269-024-01248-5","volume":"48","author":"ET Mwavika","year":"2024","unstructured":"Mwavika ET, Kunambi PP, Masasi SJ, Lema N, Kamori D, Matee M. Prevalence, rate, and predictors of virologic failure among adult HIV-Infected clients on second-line antiretroviral therapy (ART) in Tanzania (2018\u20132020): a retrospective cohort study. Bull Natl Res Centre. 2024;48(1):96.","journal-title":"Bull Natl Res Centre"},{"issue":"6","key":"904_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493\u2013505.","journal-title":"N Engl J Med"},{"issue":"5265","key":"904_CR23","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1126\/science.272.5265.1167","volume":"272","author":"JW Mellors","year":"1996","unstructured":"Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272(5265):1167\u201370.","journal-title":"Science"},{"key":"904_CR24","doi-asserted-by":"crossref","unstructured":"Asefa A, Asaye Z, Girma A, Hiko D. Predictors of clinical and immunological failure among patients on first-line antiretroviral therapy (ART) in Southwest Ethiopia. HIV\/AIDS-Research and Palliative Care. 2019:377\u2009\u2013\u200986.","DOI":"10.2147\/HIV.S234113"},{"issue":"1","key":"904_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12985-025-02988-0","volume":"22","author":"AD Abebe","year":"2025","unstructured":"Abebe AD, Tassew WC, Ferede YA, Beyene JA, Assefa M. Prevalence and determinants of virologic failure among HIV patients on ART in Africa: a systematic review and meta-analysis. Virol J. 2025;22(1):395.","journal-title":"Virol J"},{"issue":"9903","key":"904_CR26","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","volume":"382","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. lancet. 2013;382(9903):1525\u201333.","journal-title":"lancet"},{"issue":"5","key":"904_CR27","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/jac\/dkh162","volume":"53","author":"DR Bangsberg","year":"2004","unstructured":"Bangsberg DR, Moss AR, Deeks SG. Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. J Antimicrob Chemother. 2004;53(5):696\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"904_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","volume":"133","author":"DL Paterson","year":"2000","unstructured":"Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21\u201330.","journal-title":"Ann Intern Med"},{"issue":"2","key":"904_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1037\/0278-6133.23.2.207","volume":"23","author":"MR DiMatteo","year":"2004","unstructured":"DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207.","journal-title":"Health Psychol"},{"issue":"Suppl 1","key":"904_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10461-006-9141-3","volume":"10","author":"W Bikaako-Kajura","year":"2006","unstructured":"Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, Mermin J, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav. 2006;10(Suppl 1):85\u201393.","journal-title":"AIDS Behav"},{"issue":"1","key":"904_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12879-019-3924-4","volume":"19","author":"M Ahmed","year":"2019","unstructured":"Ahmed M, Merga H, Jarso H. Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study. BMC Infect Dis. 2019;19(1):305.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"904_CR32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"INSIGHT START Study Group","year":"2015","unstructured":"INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795\u2013807. https:\/\/doi.org\/10.1056\/NEJMoa1506816","journal-title":"N Engl J Med"},{"issue":"9585","key":"904_CR33","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(07)60948-9","volume":"370","author":"A Mocroft","year":"2007","unstructured":"Mocroft A, Phillips AN, Gatell J, Ledergerber B, Fisher M, Clumeck N, et al. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Lancet. 2007;370(9585):407\u201313.","journal-title":"Lancet"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-026-00904-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00904-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00904-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:06:55Z","timestamp":1787875615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12981-026-00904-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["904"],"URL":"https:\/\/doi.org\/10.1186\/s12981-026-00904-2","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the Institutional Research Ethics Review Committee of Injibara University (Ref. No.: IU\/IRERC\/125\/25). Permission to access data was granted by the Amhara Public Health Institute and the respective health facilities. The study was conducted in accordance with the Declaration of Helsinki, and confidentiality was maintained through anonymous data extraction.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"81"}}